What of the 6x or worse effectiveness against a few strains gaining currency e.g. the brazilian one? Seems still valuable under this model.
I think we need to track data about these variants and their prevalence.
What of the 6x or worse effectiveness against a few strains gaining currency e.g. the brazilian one? Seems still valuable under this model.
I think we need to track data about these variants and their prevalence.